LEADER 02440nam 2200493 450 001 9910137688803321 005 20221014071947.0 010 $a953-51-4450-2 035 $a(CKB)3230000000076846 035 $a(NjHacI)993230000000076846 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/57991 035 $a(MiAaPQ)EBC30390301 035 $a(Au-PeEL)EBL30390301 035 $a(EXLCZ)993230000000076846 100 $a20221014d2011 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aRegenerative Medicine and Tissue Engineering $eCells and Biomaterials /$fedited by Daniel Eberli 205 $a1st ed. 210 $cIntechOpen$d2011 210 1$a[Place of publication not identified] :$cIntechOpen,$d2011. 215 $a1 online resource (604 pages) 311 $a953-307-663-1 330 $aTissue Engineering may offer new treatment alternatives for organ replacement or repair deteriorated organs. Among the clinical applications of Tissue Engineering are the production of artificial skin for burn patients, tissue engineered trachea, cartilage for knee-replacement procedures, urinary bladder replacement, urethra substitutes and cellular therapies for the treatment of urinary incontinence. The Tissue Engineering approach has major advantages over traditional organ transplantation and circumvents the problem of organ shortage. Tissues reconstructed from readily available biopsy material induce only minimal or no immunogenicity when reimplanted in the patient. This book is aimed at anyone interested in the application of Tissue Engineering in different organ systems. It offers insights into a wide variety of strategies applying the principles of Tissue Engineering to tissue and organ regeneration. 606 $aTissue Engineering 606 $aRegenerative Medicine 610 $aMedicine 610 $aBiomedical Engineering 610 $aTissue Engineering and Regenerative Medicine 610 $aHealth Sciences 615 0$aTissue Engineering. 615 0$aRegenerative Medicine. 676 $a610.28 700 $aDaniel Eberli$4auth$01366151 702 $aEberli$b Daniel 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910137688803321 996 $aRegenerative Medicine and Tissue Engineering$93388669 997 $aUNINA